Acutus Medical (AFIB) Stock Price
Acutus Medical Price
Revenue has compounded at 45.0% per year over the past 6 years to 20.16 M USD. Acutus Medical's net margin stands at -47.4%, up from -1,204.9% several years earlier.
Acutus Medical stock price
Acutus Medical business model & stock analysis
Frequently asked questions about Acutus Medical
The business model of Acutus Medical Inc. revolves around medical technologies and solutions for cardiac arrhythmia treatment. Acutus Medical specializes in developing and commercializing innovative electrophysiology platforms and mapping systems that provide real-time, high-resolution mapping of the heart. With a focus on improving the accuracy and efficiency of procedures, Acutus Medical's products enable physicians to better diagnose and treat arrhythmias. The company's advanced technology aims to enhance patient outcomes and streamline healthcare delivery. Acutus Medical Inc. is committed to advancing the field of electrophysiology through continuous innovation and collaboration with healthcare professionals.
Acutus Medical Inc is primarily active in the healthcare industry, specifically focusing on medical devices and technologies for the treatment of cardiac arrhythmias. With their innovative solutions and advanced visualization technologies, Acutus Medical aims to improve the diagnosis and treatment of cardiac arrhythmias, providing physicians with real-time, precise, and detailed information to guide their procedures. By combining electrophysiology and imaging, Acutus Medical revolutionizes how cardiac arrhythmias are managed, offering potential benefits for patients and healthcare professionals in the field of cardiac care.
The main competitors of Acutus Medical Inc in the market include companies such as Biosense Webster, Abbott Laboratories, and Boston Scientific Corporation.
Acutus Medical Inc. is a medical technology company specializing in providing cardiac mapping and ablation systems for the treatment of complex arrhythmias. Founded in 2011, the company has quickly gained recognition for its innovative solutions in electrophysiology. Acutus Medical Inc. is committed to improving patients' lives by providing advanced technologies that enable physicians to diagnose and treat cardiac conditions more accurately and effectively. With a team of experienced professionals and a commitment to research and development, Acutus Medical Inc. continues to be at the forefront of advancing medical technology in the field of electrophysiology. From its inception, the company has focused on revolutionizing the way cardiac arrhythmias are diagnosed and treated, making them a trusted name in the healthcare industry.
Acutus Medical Inc has achieved several significant milestones in its history. One notable accomplishment was the development and introduction of the AcQMap imaging and mapping system, which revolutionized cardiac electrophysiology procedures by providing highly detailed 3D mapping of the heart. The company also made strides in expanding its global presence through strategic partnerships and key regulatory approvals. Moreover, Acutus Medical Inc successfully completed its initial public offering (IPO) in 2019, further strengthening its financial position and enabling continued innovation in the field of electrophysiology. These achievements have solidified Acutus Medical Inc's reputation as a leading player in the cardiac mapping and ablation market.
Acutus Medical Inc is primarily present in various countries and regions around the world. The company has a global presence, with a focus on key markets such as the United States, Europe, and Asia. Acutus Medical Inc has established a strong presence in the United States, where it is headquartered and operates its main operations. Additionally, the company has expanded its footprint in Europe, targeting countries like Germany, France, and the United Kingdom. Acutus Medical Inc is also actively present in the Asia-Pacific region, with a particular focus on markets in Japan, China, and Australia.
Acutus Medical Inc represents a strong commitment to innovation, cutting-edge technology, and delivering optimal patient care. The company's corporate philosophy focuses on developing advanced solutions for cardiac arrhythmia treatment, empowering healthcare professionals, and improving patient outcomes. Acutus Medical is dedicated to transforming the field of electrophysiology by providing precise and accurate mapping and ablation solutions, enabling customized therapy options. With a patient-centric approach, Acutus Medical strives to revolutionize the treatment of complex arrhythmias and enhance the quality of life for individuals with cardiac conditions. By continually pushing boundaries and embracing a culture of excellence, Acutus Medical is at the forefront of revolutionizing electrophysiology interventions.
6 analysts currently rate the Acutus Medical stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Acutus Medical to generate revenue of 98.80 M USD and earnings per share of -1.35 USD.
Converted at the current exchange rate, the Acutus Medical share trades at 0.00 EUR (0.00 USD).
The Acutus Medical share (AFIB) is listed on 1 stock exchanges, including: NASDAQ (AFIB).
Acutus Medical Inc is a leading company in the field of electrophysiological imaging in medicine. Through the use of state-of-the-art technology and advanced imaging solutions, the company offers a wide range of products and services for the treatment of cardiac arrhythmias.
The expected revenue of Acutus Medical is 98.80 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Acutus Medical is -40.19 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Acutus Medical is currently -0.00. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Acutus Medical stock.
The price-to-sales ratio (P/S) of Acutus Medical is currently 0.00. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Acutus Medical stock.
The Eulerpool Quality Score for Acutus Medical is 2/10.
The ISIN of Acutus Medical is US0051111096. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Acutus Medical is AFIB. The ticker symbol is used to trade Acutus Medical shares on the stock exchange.
Acutus Medical stock
Acutus Medical Peer Group
Acutus Medical Ticker
Acutus Medical FIGI
All fundamentals and in-depth analysis of Acutus Medical
Our stock analysis for Acutus Medical stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Acutus Medical. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.